Clinical effect of azithromycin as an adjunct to non-surgical treatment of chronic periodontitis: a meta-analysis of randomized controlled clinical trials

• Published in: Journal of periodontal research 2016-06, Vol.51 (3), p.275-283
• Main Authors: Zhang, Z., Zheng, Y., Bian, X.
• Format: Article
• Language: English
• Subjects: Anti-Infective Agents - administration & dosage; Anti-Infective Agents - therapeutic use; azithromycin; Azithromycin - administration & dosage; Azithromycin - therapeutic use; Chronic Periodontitis - drug therapy; Chronic Periodontitis - therapy; Dental Scaling - methods; Dentistry; Gingival Hemorrhage - drug therapy; Gingival Hemorrhage - therapy; Humans; meta-analysis; Periodontal Attachment Loss - drug therapy; Periodontal Attachment Loss - therapy; Periodontal Index; Periodontal Pocket - drug therapy; Periodontal Pocket - therapy; periodontitis; Periodontitis - drug therapy; Periodontitis - therapy; Randomized Controlled Trials as Topic; root planing; Root Planing - methods
• ISSN: 0022-3484; 1600-0765
• DOI: 10.1111/jre.12319

The results of recent published studies focusing on the effect of azithromycin as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis are inconsistent. We conducted a meta‐analysis of randomized controlled clinical trials to examine the effect of azithromycin combined with SRP on periodontal clinical parameters as compared to SRP alone. An electronic search was carried out on Pubmed, Embase and the Cochrane Central Register of Controlled Trials from their earliest records through December 28, 2014 to identify studies that met pre‐stated inclusion criteria. Reference lists of retrieved articles were also reviewed. Data were extracted independently by two authors. Either a fixed‐ or random‐effects model was used to calculate the overall effect sizes of azithromycin on probing depth, attachment level (AL) and bleeding on probing (BOP). Heterogeneity was evaluated using the Q test and I2 statistic. Publication bias was evaluated by Begg's test and Egger's test. A total of 14 trials were included in the meta‐analysis. Compared with SRP alone, locally delivered azithromycin plus SRP statistically significantly reduced probing depth by 0.99 mm (95% CI 0.42–1.57) and increased AL by 1.12 mm (95% CI 0.31–1.92). In addition, systemically administered azithromycin plus SRP statistically significantly reduced probing depth by 0.21 mm (95% CI 0.12–0.29), BOP by 4.50% (95% CI 1.45–7.56) and increased AL by 0.23 mm (95% CI 0.07–0.39). Sensitivity analysis yielded similar results. No evidence of publication bias was observed. The additional benefit of systemic azithromycin was shown at the initially deep probing depth sites, but not at shallow or moderate sites. The overall effect sizes of systemic azithromycin showed a tendency to decrease with time, and meta‐regression analysis suggested a negative relation between the length of follow‐up and net change in probing depth (r = −0.05, p = 0.02). This meta‐analysis provides further evidence that azithromycin used as an adjunct to SRP significantly improves the efficacy of non‐surgical periodontal therapy on reducing probing depth, BOP and improving AL, particularly at the initially deep probing depth sites.